Literature DB >> 11943438

The dangers of inferring treatment effects from observational data: a case study in HIV infection.

David Dunn1, Abdel Babiker, Malcolm Hooker, Janet Darbyshire.   

Abstract

Several recent articles have implicitly questioned the need for randomized controlled trials, based on a comparison of treatment effects from observational studies and related randomized controlled trials. We present here a counterexample of a comparison of two antiretroviral drugs used in the treatment of HIV infection, in which the observational analysis gave a potentially misleading result. Examples such as this emphasize the need to regard randomized controlled trials as the primary mechanism for assessing therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943438     DOI: 10.1016/s0197-2456(01)00200-8

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  4 in total

Review 1.  Clinical trials of antiretroviral drugs: the role of the MRC AIDS Therapeutic Trials Committee (ATTC) and the MRC Clinical Trials Unit (CTU).

Authors:  Janet Darbyshire
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

2.  Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.

Authors:  Stéphanie Payet; Philippe Denis; Gilles Berdeaux; Robert Launois
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

3.  Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database.

Authors:  Philippe Denis; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2008-06

Review 4.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.